Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort

References

• Alberti KGMM, Zimmet P, Shaw J, IDF Epidemiology Task Force Consensus Group. (2005). The metabolic syndrome–a new worldwide definition. Lancet. 366:1059–62.
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association, A.P.A. (2000). Diagnostic and statistical manual of mental disorders DSM-IV-TR. 4th edition. Arlington: American Psychiatric Publishing, Inc.
   Google Scholar
• Anderson G, Jacob A, Bellivier F, Geoffroy PA. (2016). Bipolar disorder: The role of the kynurenine and melatonergic pathways. Curr Pharm Des. 22:987–1012.
   PubMed Web of Science ®Google Scholar
• Andrew JE, Wileman SM, Howie FL, et al. (2001). Comparison of consultation rates in primary care attenders with and without seasonal affective disorder. J Affect Disord. 62:199–205.
   PubMed Web of Science ®Google Scholar
• Balkau B, Vernay M, Mhamdi L, et al. (2003). The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabetes Metab. 29:526–32.
   PubMed Web of Science ®Google Scholar
• Baune BT, Adrian I, Arolt V, Berger K. (2006). Associations between major depression, bipolar disorders, dysthymia and cardiovascular diseases in the general adult population. Psychother Psychosom. 75:319–26.
   PubMed Web of Science ®Google Scholar
• Benard V, Geoffroy PA, Bellivier F. (2015). Seasons, circadian rhythms, sleep and suicidal behaviors vulnerability. Encephale. 41:S29–A37.
   PubMedGoogle Scholar
• Blais FC, Gendron L, Mimeault V, Morin CM. (1997). [Evaluation of insomnia: Validity of 3 questionnaires]. Encephale. 23:447–53.
   PubMed Web of Science ®Google Scholar
• Boerman R, Cohen D, Schulte PFJ, Nugter A. (2016). Prevalence of vitamin D deficiency in adult outpatients with bipolar disorder or schizophrenia. J Clin Psychopharmacol. 36:588–92.
   PubMed Web of Science ®Google Scholar
• Chesney E, Goodwin GM, Fazel S. (2014). Risks of all-cause and suicide mortality in mental disorders: A meta-review. World Psychiatry. 13:153–60.
   PubMed Web of Science ®Google Scholar
• Cheung A, Dewa C, Michalak EE, et al. (2012). Direct health care costs of treating seasonal affective disorder: A comparison of light therapy and fluoxetine. Depress Res Treat. (2012:628434.
   PubMedGoogle Scholar
• Crump C, Sundquist K, Winkleby MA, Sundquist J. (2013). Comorbidities and mortality in bipolar disorder: A Swedish national cohort study. JAMA Psychiatry. 70:931–39.
   PubMed Web of Science ®Google Scholar
• Eckel RH, Grundy SM, Zimmet PZ. (2005). The metabolic syndrome. Lancet. 365:1415–28.
   PubMed Web of Science ®Google Scholar
• First MB, Spitzer RL, Gibbon M, and Williams JBW. (1996). Structured Clinical Interview for DSM-IV Axis I Disorders, Clinician Version (SCID-CV). Washington, D.C.: American Psychiatric Press, Inc.
   Google Scholar
• Geddes JR, Miklowitz DJ. (2013). Treatment of bipolar disorder. Lancet. 381:1672–82.
   PubMed Web of Science ®Google Scholar
• Geoffroy PA, Bellivier F, Scott J, et al. (2013). Bipolar disorder with seasonal pattern: Clinical characteristics and gender influences. Chronobiol Int. 30:1101–07.
   PubMed Web of Science ®Google Scholar
• Geoffroy PA, Bellivier F, Scott J, Etain B. (2014). Seasonality and bipolar disorder: A systematic review, from admission rates to seasonality of symptoms. J Affect Disord. 168C:210–23.
   Web of Science ®Google Scholar
• Geoffroy PA, Etain B, Franchi J-AM, et al. (2015a). Melatonin and melatonin agonists as adjunctive treatments in bipolar disorders. Curr Pharm Des. 21:3352–58.
   PubMed Web of Science ®Google Scholar
• Geoffroy PA, Fovet T, Micoulaud-Franchi J-A, et al. (2015b). Bright light therapy in seasonal bipolar depressions. Encephale. 41:527–33.
   PubMed Web of Science ®Google Scholar
• Gerber M, Hoffman R. (2015). The Mediterranean diet: Health. Sci Soc Br J Nutr. 113:S4–10.
   PubMed Web of Science ®Google Scholar
• Gignac A, McGirr A, Lam RW, Yatham LN. (2015). Recovery and recurrence following a first episode of mania: A systematic review and meta-analysis of prospectively characterized cohorts. J Clin Psychiatry. 76:1241–48.
   PubMed Web of Science ®Google Scholar
• Golden RN, Gaynes BN, Ekstrom RD, et al. (2005). The efficacy of light therapy in the treatment of mood disorders: A review and meta-analysis of the evidence. Am J Psychiatry. 162:656–62.
   PubMed Web of Science ®Google Scholar
• Hallam KT, Olver JS, Chambers V, et al. (2006). The heritability of melatonin secretion and sensitivity to bright nocturnal light in twins. Psychoneuroendocrinology. 31:867–75.
   PubMed Web of Science ®Google Scholar
• Hardin TA, Wehr TA, Brewerton T, et al. (1991). Evaluation of seasonality in six clinical populations and two normal populations. J Psychiatr Res. 25:75–87.
   PubMed Web of Science ®Google Scholar
• Harvey AG. (2008). Sleep and circadian rhythms in bipolar disorder: Seeking synchrony, harmony, and regulation. Am J Psychiatry. 165:820–29.
   PubMed Web of Science ®Google Scholar
• Hayes JF, Miles J, Walters K, et al. (2015). A systematic review and meta-analysis of premature mortality in bipolar affective disorder. Acta Psychiatr Scand. 131:417–25.
   PubMed Web of Science ®Google Scholar
• Henry C, Etain B, Godin O, et al. (2015). Bipolar patients referred to specialized services of care: Not resistant but impaired by sub-syndromal symptoms. Results from the FACE-BD Cohort. Aust N Z J Psychiatry. 49:898–905.
   PubMed Web of Science ®Google Scholar
• Kaneko I, Sabir MS, Dussik CM, et al. (2015). 1,25-Dihydroxyvitamin D regulates expression of the tryptophan hydroxylase 2 and leptin genes: Implication for behavioral influences of vitamin D. Faseb J. 29:4023–35.
   PubMed Web of Science ®Google Scholar
• Karthick S, Kattimani S, Sarkar S, et al. (2015). Quality of sleep in patients with bipolar I disorder during remission. J Psychiatr Pract. 21:419–26.
   PubMed Web of Science ®Google Scholar
• Kennedy SH, Kutcher SP, Ralevski E, Brown GM. (1996). Nocturnal melatonin and 24-hour 6-sulphatoxymelatonin levels in various phases of bipolar affective disorder. Psychiatry Res. 63:219–22.
   PubMed Web of Science ®Google Scholar
• Kessing LV, Vradi E, McIntyre RS, Andersen PK. (2015). Causes of decreased life expectancy over the life span in bipolar disorder. J Affect Disord. 180:142–47.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Petukhova M, Sampson NA, et al. (2012). Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 21:169–84.
   PubMed Web of Science ®Google Scholar
• Kim JS, Ha TH, Chang JS, et al. (2015). Seasonality and its distinct clinical correlates in bipolar II disorder. Psychiatry Res. 225:540–44.
   PubMed Web of Science ®Google Scholar
• Kodesh A, Goldshtein I, Gelkopf M, et al. (2012). Epidemiology and comorbidity of severe mental illnesses in the community: Findings from a computerized mental health registry in a large Israeli health organization. Soc Psychiatry Psychiatr Epidemiol. 47:1775–82.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Wahlbeck K, Hällgren J, et al. (2013). Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. Plos One. 8:e67133.
   PubMed Web of Science ®Google Scholar
• Leboyer M, Soreca I, Scott J, et al. (2012). Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord. 141:1–10.
   PubMed Web of Science ®Google Scholar
• Magnusson A, Partonen T. (2005). The diagnosis, symptomatology, and epidemiology of seasonal affective disorder. CNS Spectr. 10:625-634-14.
   PubMed Web of Science ®Google Scholar
• Markus RP, Cecon E, Pires-Lapa MA. (2013). Immune-pineal axis: Nuclear factor κB (NF-kB) mediates the shift in the melatonin source from pinealocytes to immune competent cells. Int J Mol Sci. 14:10979–97.
   PubMed Web of Science ®Google Scholar
• Martin DJ, Ul-Haq Z, Nicholl BI, et al. (2016). Cardiometabolic disease and features of depression and bipolar disorder: Population-based, cross-sectional study. Br J Psychiatry. 208(4):343–51. bjp.bp.114.157784.
   Web of Science ®Google Scholar
• McClung CA. (2011). Circadian rhythms and mood regulation: Insights from pre-clinical models. Eur Neuropsychopharmacol. 21:S683–693.
   PubMed Web of Science ®Google Scholar
• McClung CA. (2013). How might circadian rhythms control mood? Let me count the ways. Biol Psychiatry. 74:242–49.
   PubMed Web of Science ®Google Scholar
• McIntyre IM, Norman TR, Burrows GD, Armstrong SM. (1989). Human melatonin suppression by light is intensity dependent. J Pineal Res. 6:149–56.
   PubMed Web of Science ®Google Scholar
• Merikangas KR, Akiskal HS, Angst J, et al. (2007). Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 64:543–52.
   PubMed Web of Science ®Google Scholar
• Michalak EE, Murray G, Levitt AJ, et al. (2007). Quality of life as an outcome indicator in patients with seasonal affective disorder: Results from the Can-SAD study. Psychol Med. 37:727–36.
   PubMed Web of Science ®Google Scholar
• Misdrahi D, Verdoux H, Llorca P-M, Baylé F-J. (2004). [Therapeutic adherence and schizophrenia: The interest of the validation of the French translation of Medication Adherence Rating Scale (MARS)]. Encephale. 30:409–10.
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. (1979). A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:382–89.
   PubMed Web of Science ®Google Scholar
• Nurnberger JI Jr, Adkins S, Lahiri DK, et al. (2000). Melatonin suppression by light in euthymic bipolar and unipolar patients. Arch Gen Psychiatry. 57:572–79.
   PubMed Web of Science ®Google Scholar
• Nurnberger JI Jr, Berrettini W, Tamarkin L, et al. (1988). Supersensitivity to melatonin suppression by light in young people at high risk for affective disorder. A preliminary report. Neuropsychopharmacology. 1:217–23.
   PubMed Web of Science ®Google Scholar
• Nussbaumer B, Kaminski-Hartenthaler A, Forneris CA, et al. (2015). Light therapy for preventing seasonal affective disorder. Cochrane Database Syst Rev. 11:CD011269.
   Google Scholar
• Pacchierotti C, Iapichino S, Bossini L, et al. (2001). Melatonin in psychiatric disorders: A review on the melatonin involvement in psychiatry. Front Neuroendocrinol. 22:18–32.
   PubMed Web of Science ®Google Scholar
• Pannier B, Thomas F, Eschwège E, et al. (2006). Cardiovascular risk markers associated with the metabolic syndrome in a large French population: The “SYMFONIE” study. Diabetes Metab. 32:467–74.
   PubMed Web of Science ®Google Scholar
• Perlis RH, Ostacher MJ, Patel JK, et al. (2006). Predictors of recurrence in bipolar disorder: Primary outcomes from the systematic treatment enhancement program for bipolar disorder (STEP-BD). Am J Psychiatry. 163:217–24.
   PubMed Web of Science ®Google Scholar
• Rintamäki R, Grimaldi S, Englund A, et al. (2008). Seasonal changes in mood and behavior are linked to metabolic syndrome. Plos One. 3:e1482.
   PubMed Web of Science ®Google Scholar
• Romo-Nava F, Alvarez-Icaza González D, Fresán-Orellana A, et al. (2014). Melatonin attenuates antipsychotic metabolic effects: An eight-week randomized, double-blind, parallel-group, placebo-controlled clinical trial. Bipolar Disord. 16:410–21.
   PubMed Web of Science ®Google Scholar
• Rouillon F, Van Ganse E, Vekhoff P, et al. (2015). Vigilance level for cardiovascular risk factors in schizophrenic patients. Encephale. 41:70–77.
   PubMed Web of Science ®Google Scholar
• Stoleru D, Nawathean P, Fernández MSLP, et al. (2007). The Drosophila circadian network is a seasonal timer. Cell. 129:207–19.
   PubMed Web of Science ®Google Scholar
• Tu BP, McKnight SL. (2006). Metabolic cycles as an underlying basis of biological oscillations. Nat Rev Mol Cell Biol. 7:696–701.
   PubMed Web of Science ®Google Scholar
• Uzoma HN, Reeves GM, Langenberg P, et al. (2015). Light treatment for seasonal winter depression in African-American vs caucasian outpatients. World J Psychiatry. 5:138–46.
   PubMed Web of Science ®Google Scholar
• Vancampfort D, Correll CU, Wampers M, et al. (2014). Metabolic syndrome and metabolic abnormalities in patients with major depressive disorder: A meta-analysis of prevalences and moderating variables. Psychol Med. 44:2017–28.
   PubMed Web of Science ®Google Scholar
• Vancampfort D, Stubbs B, Mitchell AJ, et al. (2015). Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: A systematic review and meta-analysis. World Psychiatry. 14:339–47.
   PubMed Web of Science ®Google Scholar
• Vancampfort D, Vansteelandt K, Correll CU, et al. (2013). Metabolic syndrome and metabolic abnormalities in bipolar disorder: A meta-analysis of prevalence rates and moderators. Am J Psychiatry. 170:265–74.
   PubMed Web of Science ®Google Scholar
• Vázquez GH, Holtzman JN, Lolich M, et al. (2015). Recurrence rates in bipolar disorder: Systematic comparison of long-term prospective, naturalistic studies versus randomized controlled trials. Eur Neuropsychopharmacol. 25:1501–12.
   PubMed Web of Science ®Google Scholar
• Volkert J, Schiele MA, Kazmaier J, et al. (2015). Cognitive deficits in bipolar disorder: From acute episode to remission. Eur Arch Psychiatry Clin Neurosci. 266(3):225–37.
   PubMed Web of Science ®Google Scholar
• Walker ER, McGee RE, Druss BG. (2015). Mortality in mental disorders and global disease burden implications: A systematic review and meta-analysis. JAMA Psychiatry. 72:334–41.
   PubMed Web of Science ®Google Scholar
• Young RC, Biggs JT, Ziegler VE, Meyer DA. (1978). A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry. 133:429–35.
   PubMed Web of Science ®Google Scholar
• Zhang J, Kaasik K, Blackburn MR, Lee CC. (2006). Constant darkness is a circadian metabolic signal in mammals. Nature. 439:340–43.
   PubMed Web of Science ®Google Scholar